Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 3460.0
(0.29%)
JPY 3460.0
(0.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 102.88 Billion | 103.26 Billion | 110.17 Billion | 102.99 Billion | 101.8 Billion | 109.65 Billion |
| Cost of Revenue | 50.81 Billion | 48.14 Billion | 50.62 Billion | 48.2 Billion | 49.88 Billion | 55.47 Billion |
| Gross Profit | 52.07 Billion | 55.11 Billion | 59.55 Billion | 54.79 Billion | 51.91 Billion | 54.17 Billion |
| Operating Expenses | 46.26 Billion | 46.6 Billion | 45.16 Billion | 42.78 Billion | 43.11 Billion | 43.58 Billion |
| Selling, General and Administrative Expenses | 33.71 Billion | 33.32 Billion | 32.86 Billion | 31.93 Billion | 31.22 Billion | 30.58 Billion |
| Research and Development Expenses | 12.55 Billion | 13.28 Billion | 12.29 Billion | 10.84 Billion | 11.88 Billion | 13 Billion |
| Other Expenses | - | 108 Million | 119 Million | 104 Million | 109 Million | 119 Million |
| Cost and Expenses | 97.08 Billion | 94.75 Billion | 95.78 Billion | 90.99 Billion | 92.99 Billion | 99.06 Billion |
| Operating Income | 5.8 Billion | 8.5 Billion | 14.39 Billion | 12 Billion | 8.8 Billion | 10.59 Billion |
| Interest Expense | 2 Million | - | 2 Million | - | - | 1 Million |
| Income Tax Expense | 1.61 Billion | 2.39 Billion | 4.02 Billion | 3.31 Billion | 1.67 Billion | 3.2 Billion |
| Earnings before Tax | 6.16 Billion | 9.04 Billion | 14.59 Billion | 11.9 Billion | 6.27 Billion | 11.64 Billion |
| Net Income | 4.54 Billion | 6.64 Billion | 10.56 Billion | 8.58 Billion | 4.59 Billion | 8.43 Billion |
| Earnings Per Share Basic | 126.79 | 178.93 | 277.39 | 222.27 | 117.55 | 212.86 |
| Earnings Per Share Diluted | 126.79 | 178.93 | 277.39 | 222.27 | 117.55 | 212.86 |
| Weighted Average Shares Outstanding | 35.86 Million | 37.16 Million | 38.1 Million | 38.63 Million | 39.11 Million | 39.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.86 Million | 37.16 Million | 38.1 Million | 38.63 Million | 39.11 Million | 39.62 Million |
| Gross Margin | 0.51 | 0.53 | 0.54 | 0.53 | 0.51 | 0.49 |
| EBIT Margin | 0.09 | 0.11 | 0.16 | 0.15 | 0.14 | 0.13 |
| Profit Margin | 0.04 | 0.06 | 0.10 | 0.08 | 0.05 | 0.08 |
| EBITDA | 8.97 Billion | 11.71 Billion | 17.28 Billion | 14.74 Billion | 11.53 Billion | 14.55 Billion |
| Earnings Before Tax Margin | 0.06 | 0.08 | 0.13 | 0.12 | 0.09 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.68 Billion | 25.4 Billion | 102.88 Billion | 24.66 Billion | 28.74 Billion | 24.72 Billion |
| Cost of Revenue | 13.36 Billion | 12.45 Billion | 50.81 Billion | 12.94 Billion | 13.91 Billion | 12.41 Billion |
| Gross Profit | 12.32 Billion | 12.95 Billion | 52.07 Billion | 11.72 Billion | 14.82 Billion | 12.31 Billion |
| Operating Expenses | 10.72 Billion | 10.79 Billion | 46.26 Billion | 11.71 Billion | 12.98 Billion | 10.87 Billion |
| Selling, General and Administrative Expenses | 10.72 Billion | 10.76 Billion | - | 8.18 Billion | 8.81 Billion | 8.52 Billion |
| Research and Development Expenses | - | 2.32 Billion | - | 3.52 Billion | 4.17 Billion | 2.35 Billion |
| Other Expenses | - | - | 102 Million | 34 Million | 33 Million | 5 Million |
| Cost and Expenses | 24.08 Billion | 23.24 Billion | 97.08 Billion | 24.65 Billion | 26.9 Billion | 23.29 Billion |
| Operating Income | 1.6 Billion | 2.19 Billion | 5.8 Billion | 11 Million | 1.83 Billion | 1.43 Billion |
| Interest Expense | - | - | 2 Million | 1 Million | 1 Million | - |
| Income Tax Expense | 433 Million | 809 Million | 1.61 Billion | 14 Million | 389 Million | 326 Million |
| Earnings before Tax | 1.7 Billion | 2.36 Billion | 6.16 Billion | 117 Million | 1.99 Billion | 1.47 Billion |
| Net Income | 1.27 Billion | 1.55 Billion | 4.54 Billion | 103 Million | 1.6 Billion | 1.15 Billion |
| Earnings Per Share Basic | 35.85 | 43.83 | - | 3.32 | 45.16 | 32.28 |
| Earnings Per Share Diluted | 35.85 | 43.83 | - | 3.32 | 45.16 | 32.28 |
| Weighted Average Shares Outstanding | 35.45 Million | 35.45 Million | 35.86 Million | 35.47 Million | 35.56 Million | 35.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.45 Million | 35.45 Million | 35.86 Million | 35.47 Million | 35.56 Million | 35.62 Million |
| Gross Margin | 0.48 | 0.51 | 0.51 | 0.48 | 0.52 | 0.50 |
| EBIT Margin | 0.09 | 0.01 | - | 0.03 | 0.07 | 0.06 |
| Profit Margin | 0.05 | 0.06 | 0.04 | 0.00 | 0.06 | 0.05 |
| EBITDA | 2.41 Billion | 173 Million | - | 761 Million | 2 Billion | 1.46 Billion |
| Earnings Before Tax Margin | 0.06 | 0.09 | 0.06 | 0.00 | 0.06 | 0.06 |
RHIM
EDTXF
SPOK
ALIT
RCM
6794